SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-054087
Filing Date
2021-08-31
Accepted
2021-08-31 16:37:50
Documents
2
Period of Report
2021-08-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1669
2 POA DOCUMENT poa.txt EX-24.3_1006484 4127
  Complete submission text file 0001209191-21-054087.txt   7326
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZIOPHARM ONCOLOGY, INC. ONE FIRST AVENUE, PARRIS BLDG 34 BOSTON MA 02129
Business Address
Boyle Kevin S. Sr. (Reporting) CIK: 0001880600 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33038 | Film No.: 211227452